Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 913 results found. Search for [ icmr ]

Results 20 to 40 of 913
BusinessToday.In
January 4, 2021
The phase-2 trials of Zydus Cadila's coronavirus vaccine had been conducted in around 1,000 healthy adults


BusinessToday.In
January 3, 2021
The ICMR head emphasised that the scientists at ICMR have been successfully able to culture the UK strain and the efficacy of Covaxin against it will be further tested in days to come


BusinessToday.In
January 3, 2021
Flight bookings for travel between India and the UK have started. Air India said in a tweet that \"Booking for Air India flights between India & UK is open now\"


BusinessToday.In
January 3, 2021
COVID-19 vaccine in India: It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India! This shows the eagerness of our scientific community to fulfil the dream of an Aatmanirbhar Bharat, said PM Modi


BusinessToday.In
January 3, 2021
COVID-19 vaccines in India: Oxford-AstraZeneca's coronavirus vaccine Covishield and Bharat Biotech's COVID vaccine Covaxin will be India's first vaccines


BusinessToday.In
January 3, 2021
Coronavirus pandemic: In December, the UK government reported a variant, which was referred to as SARS-CoV-2 VOC 202012/01. This variant is not phylogenetically related to the SARS-CoV-2 virus


PTI
January 3, 2021
The research body said vero cell lines were used by the scientists of ICMR-NIV to culture the UK-variant of the virus


BusinessToday.In
January 3, 2021
Coronavirus vaccine trials: Bharat Biotech said that it is steadily moving towards its goal of 26,000 volunteers. Phase 3 of human clinical trials for Covaxin began in mid-November


BusinessToday.In
January 2, 2021
The SEC has recommended Covaxin for emergency use authorisation; the recommendation, along with rollout modalities, will now be taken up by the DCGI for a final decision on the matter


BusinessToday.In
January 2, 2021
Experts will review the indigenously developed vaccine a day after the Subject Expert Committee (SEC) had recommended Serum-Oxford's Covishield COVID-19 vaccine to the Drugs Controller General of India (DCGI) for emergency use authorisation


PTI
January 2, 2021
The number of people who have recuperated from the disease surged to 99,06,387, pushing the national recovery rate to 96.12 per cent, while the COVID-19 case fatality rate stood at 1.45 per cent


Manoj Sharma
December 31, 2020
Suffering poor financial health, Central government has not given a concrete answer on who will bear the cost of vaccinating Indians - Centre, states, or the people themselves


PTI
December 31, 2020
The number of people who have recuperated from the disease surged to 98,60,280 pushing the national recovery rate to 96.04 percent, while the COVID-19 case fatality rate stands at 1.45 percent


BusinessToday.In
December 30, 2020
While also economising passengers' time, the prompt results offered by the test also enable travellers to make necessary measures to prevent transmission in quicker time, if tested positive


BusinessToday.In
New Delhi, December 30, 2020
India Inc saw 568.5% jump in profit but still fired employees, reports private think tank CMIE; UK needs tighter COVID rules to avert new \"catastrophe\", a leading epidemiologist and government advisor warned; French fashion designer Pierre Cardin passes away at age 98. Watch this and more news on News Blast.Also Read: Oxford-AstraZeneca Covid-19 vaccine approved in UK; nod in India expected soon


Reuters
December 30, 2020
The result is based on interim analysis of data from its Phase III clinical trial


Rashi Bisaria
New Delhi, December 30, 2020
Covaxin can protect against COVID-19 mutant: Bharat Biotech Covaxin, a vaccine candidate being developed by Bharat Biotech for COVID-19, can offer protection against mutations of coronavirus, Chairman and Managing Director of the city-based vaccine maker, Krishna Ella, said on Tuesday. He also said the company has approached regulatory authorities seeking approval for an emergency license to use the vaccine, developed in collaboration with the Indian Council of Medical Research (ICMR) and t...


BusinessToday.In
December 29, 2020
It is important from the scientific community perspective that we do not put too much immune pressure on the virus, said Bhargava


PTI
December 29, 2020
Bharat Biotech MD also said the company has approached regulatory authorities seeking approval for an emergency license to use the vaccine, developed in collaboration with ICMR and the National Institute of Virology and now undergoing phase 3 trials


PTI
December 29, 2020
The number of people who have recuperated from the disease surged to 98,07,569 pushing the national recovery rate to 95.92 per cent,while the COVID-19 case fatality rate stands at 1.45 per cent


PAGES 2 OF 46  12345